DHH-B MAX

OVERVIEW

DHH-B exerts its biological effects through multiple mechanisms, contributing to its diverse pharmacological activities. One of its primary mechanisms of action is through GABAergic modulation. It acts as a positive allosteric modulator of gamma-aminobutyric acid (GABA) receptors, enhancing GABAergic neurotransmission.

In addition to its GABAergic effects, DHH-B also influences the release and reuptake of various other neurotransmitters, including dopamine, serotonin, and norepinephrine. By promoting levels of these neurotransmitters, DHH-B exhibits potential support for mood, relaxation, and coganative function.

Another important aspect of DHH-B is its ability to support the production of cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukins (IL-1β, IL-6).

Furthermore, DHH-B displays robust antioxidant properties. It is a scavenger of reactive oxygen species (ROS) and upregulates endogenous antioxidant enzymes. These antioxidant effects contribute to its neuroprotective and anti-aging properties. DHH-B’s antioxidant and neuroprotective properties make it a candidate for supporting neurologic physiology and functionality to promote both short term and long term brain health.

1. Lin Y, Li Y, Zeng Y, Tian B, Qu X, Yuan Q, Song Y. Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update. Front Pharmacol. 2021 Mar 17;12:632767. doi: 10.3389/fphar.2021.632767. PMID: 33815113; PMCID: PMC8010308.

2. Shen JL, Man KM, Huang PH, Chen WC, Chen DC, Cheng YW, Liu PL, Chou MC, Chen YH. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules. 2010 Sep 16;15(9):6452-65. doi: 10.3390/molecules15096452. PMID: 20877235; PMCID: PMC6257695.

3. Hou Y, Aboukhatwa MA, Lei DL, Manaye K, Khan I, Luo Y. Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacology. 2010 May;58(6):911-20. doi: 10.1016/j.neuropharm.2009.11.002. Epub 2009 Nov 14. PMID: 19917299; PMCID: PMC2838959.

4. Woo SM, Seo SU, Kubatka P, Min KJ, Kwon TK. Honokiol Enhances TRAIL-Mediated Apoptosis through STAMBPL1-Induced Survivin and c-FLIP Degradation. Biomolecules. 2019 Dec 6;9(12):838. doi: 10.3390/biom9120838. PMID: 31817770; PMCID: PMC6995549.

5. Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP. Honokiol: a novel natural agent for cancer prevention and therapy. Curr Mol Med. 2012 Dec;12(10):1244-52. doi: 10.2174/156652412803833508. PMID: 22834827; PMCID: PMC3663139.